New evidence identified on safety of IVF embryo screening method

Researchers at the University of Kent have identified crucial new evidence on the safety and efficacy of a controversial area of IVF treatment – preimplantation genetic testing for aneuploidy (PGT-A).

PGT-A is the screening for gross genetic (chromosomal) abnormalities in human IVF embryos with a view to improving IVF success rates and guarding against miscarriage. The UK Human Fertilisation and Embryology Authority’s (HFEA) however recently assigned it a “red light” in terms of its safety and efficacy. The current study provides strong evidence for the benefits of PGT-A.

Source: Obs Gynae &Midwifery News